Real-time enrollment status for this kidney cancer clinical trial
Current Status
Suspended
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05928806 |
| Recruiting Status | Suspended |
| Condition | Kidney Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Michael B. Atkins, MD |
| Last Updated on CT.gov | February 11, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05928806 is currently suspended participants. This clinical trial study for kidney cancer is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Michael B. Atkins, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05928806 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05928806 was last updated 2 weeks ago (February 11, 2026). HelloStudys verifies this status automatically.